OKUR
OKUR reports financial results, advancing leads
OnKure Therapeutics reported Q2 2026 results with $176M cash runway until 2029, while advancing PI3Kα pan-mutant inhibitor pipeline candidates for IND submissions in 1H 2027.
OKUR news
Latest 1 stories · newest Aug 4, 2026
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same OKUR feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/OKUR/newsSTART FREE